105 related articles for article (PubMed ID: 15843032)
1. Leukemia inhibitory factor blocks early differentiation of skeletal muscle cells by activating ERK.
Jo C; Kim H; Jo I; Choi I; Jung SC; Kim J; Kim SS; Jo SA
Biochim Biophys Acta; 2005 Apr; 1743(3):187-97. PubMed ID: 15843032
[TBL] [Abstract][Full Text] [Related]
2. GDNF-induced leukemia inhibitory factor can mediate differentiation via the MEK/ERK pathway in pheochromocytoma cells derived from nf1-heterozygous knockout mice.
Park JI; Powers JF; Tischler AS; Strock CJ; Ball DW; Nelkin BD
Exp Cell Res; 2005 Feb; 303(1):79-88. PubMed ID: 15572029
[TBL] [Abstract][Full Text] [Related]
3. Cardiotrophin-1 maintains the undifferentiated state in skeletal myoblasts.
Miyake T; Alli NS; Aziz A; Knudson J; Fernando P; Megeney LA; McDermott JC
J Biol Chem; 2009 Jul; 284(29):19679-93. PubMed ID: 19439412
[TBL] [Abstract][Full Text] [Related]
4. bFGF and LIF signaling activates STAT3 in proliferating myoblasts.
Megeney LA; Perry RL; LeCouter JE; Rudnicki MA
Dev Genet; 1996; 19(2):139-45. PubMed ID: 8900046
[TBL] [Abstract][Full Text] [Related]
5. Extracellular signal-regulated kinase 1/2 mitogen-activated protein kinase pathway is involved in myostatin-regulated differentiation repression.
Yang W; Chen Y; Zhang Y; Wang X; Yang N; Zhu D
Cancer Res; 2006 Feb; 66(3):1320-6. PubMed ID: 16452185
[TBL] [Abstract][Full Text] [Related]
6. Lactoferrin promotes murine C2C12 myoblast proliferation and differentiation and myotube hypertrophy.
Kitakaze T; Oshimo M; Kobayashi Y; Ryu M; Suzuki YA; Inui H; Harada N; Yamaji R
Mol Med Rep; 2018 Apr; 17(4):5912-5920. PubMed ID: 29436684
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-11 (IL11) inhibits myogenic differentiation of C2C12 cells through activation of extracellular signal-regulated kinase (ERK).
Drinkwater K; Anderson B; Seangmany N; Hampel D; Mody A; Shim M
Cell Signal; 2023 Jan; 101():110509. PubMed ID: 36328118
[TBL] [Abstract][Full Text] [Related]
8. [Cloning, eukaryotic expression and function assay of recombinant leukemia inhibitory factor gene LIF].
Ning HX; Chen Y; Rong Y; Zhang XF; Chang ZJ
Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2003 Dec; 35(12):1123-7. PubMed ID: 14673505
[TBL] [Abstract][Full Text] [Related]
9. Leukemia inhibitory factor-induced Stat3 signaling suppresses fibroblast growth factor 1-induced Erk1/2 activation to inhibit the downstream differentiation in mouse embryonic stem cells.
Liu JW; Hsu YC; Kao CY; Su HL; Chiu IM
Stem Cells Dev; 2013 Apr; 22(8):1190-7. PubMed ID: 23205673
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-1beta can mediate growth arrest and differentiation via the leukemia inhibitory factor/JAK/STAT pathway in medullary thyroid carcinoma cells.
Park JI; Strock CJ; Ball DW; Nelkin BD
Cytokine; 2005 Feb; 29(3):125-34. PubMed ID: 15613280
[TBL] [Abstract][Full Text] [Related]
11. Deficient leukemia inhibitory factor signaling in muscle precursor cells from patients with type 2 diabetes.
Broholm C; Brandt C; Schultz NS; Nielsen AR; Pedersen BK; Scheele C
Am J Physiol Endocrinol Metab; 2012 Jul; 303(2):E283-92. PubMed ID: 22649064
[TBL] [Abstract][Full Text] [Related]
12. Nuclear exclusion of forkhead box O and Elk1 and activation of nuclear factor-kappaB are required for C2C12-RasV12C40 myoblast differentiation.
De Alvaro C; Nieto-Vazquez I; Rojas JM; Lorenzo M
Endocrinology; 2008 Feb; 149(2):793-801. PubMed ID: 17962350
[TBL] [Abstract][Full Text] [Related]
13. EPA and DHA Inhibit Myogenesis and Downregulate the Expression of Muscle-related Genes in C2C12 Myoblasts.
Zhang J; Xu X; Liu Y; Zhang L; Odle J; Lin X; Zhu H; Wang X; Liu Y
Genes (Basel); 2019 Jan; 10(1):. PubMed ID: 30669396
[TBL] [Abstract][Full Text] [Related]
14. The chemokine SDF1 controls multiple steps of myogenesis through atypical PKCzeta.
Odemis V; Boosmann K; Dieterlen MT; Engele J
J Cell Sci; 2007 Nov; 120(Pt 22):4050-9. PubMed ID: 17971416
[TBL] [Abstract][Full Text] [Related]
15. Leukemia inhibitory factor-dependent increase in myoblast cell number is associated with phosphotidylinositol 3-kinase-mediated inhibition of apoptosis and not mitosis.
Hunt LC; Tudor EM; White JD
Exp Cell Res; 2010 Apr; 316(6):1002-9. PubMed ID: 19962978
[TBL] [Abstract][Full Text] [Related]
16. In vitro myoblast to myotube transformations in the presence of leukemia inhibitory factor.
Vakakis N; Bower J; Austin L
Neurochem Int; 1995; 27(4-5):329-35. PubMed ID: 8845733
[TBL] [Abstract][Full Text] [Related]
17. Interleukin 17 inhibits myogenic and promotes osteogenic differentiation of C2C12 myoblasts by activating ERK1,2.
Kocić J; Santibañez JF; Krstić A; Mojsilović S; Dorđević IO; Trivanović D; Ilić V; Bugarski D
Biochim Biophys Acta; 2012 Apr; 1823(4):838-49. PubMed ID: 22285818
[TBL] [Abstract][Full Text] [Related]
18. MEK1 plays contrary stage-specific roles in skeletal myogenic differentiation.
Jo C; Jang BG; Jo SA
Cell Signal; 2009 Dec; 21(12):1910-7. PubMed ID: 19733237
[TBL] [Abstract][Full Text] [Related]
19. Ankyrin repeat and suppressor of cytokine signaling (SOCS) box-containing protein (ASB) 15 alters differentiation of mouse C2C12 myoblasts and phosphorylation of mitogen-activated protein kinase and Akt.
McDaneld TG; Spurlock DM
J Anim Sci; 2008 Nov; 86(11):2897-902. PubMed ID: 18641171
[TBL] [Abstract][Full Text] [Related]
20. Extracellular signal-regulated kinase 1/2 mitogen-activated protein kinase pathway is involved in inhibition of myogenic differentiation of myoblasts by hypoxia.
Li X; Wang X; Zhang P; Zhu L; Zhao T; Liu S; Wu Y; Chen X; Fan M
Exp Physiol; 2012 Feb; 97(2):257-64. PubMed ID: 22002869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
